Daily Record Jan 25, 2016 By David Taylor
Multiple sclerosis patient Lucy Clarke is the first Scot to successfully have the radical stem cell treatment that’s being hailed as “miraculous” by experts. Medics are now hopeful that it could eradicate the degenerative neurological condition.
Lucy, from Inverness, had to raise £40,000 for treatment in Moscow as she didn’t qualify for a trial in the UK. But now she’s able to live a more pain-free life …
The Star Jan 19, 2016
Paralysed multiple sclerosis sufferers are walking again thanks to life-changing treatment in Sheffield.
A trial at the Royal Hallamshire Hospital has seen 20 patients receive bone marrow transplants using their own stem cells in a bid to ‘re-boot’ their immune systems, which has helped some people walk again.
The trial is also being run in the US, Sweden and Brazil.
Professor Basil Sharrack, from the Royal Hallamshire Hospital, said: “To …
LA Times Dec 3, 2015 Melissa Healy
An international conference on gene editing on Thursday left the door open to future use, in humans, of new techniques that alter an organism’s genetic architecture in ways that carry forward to future generations.
With questions of safety, need and ethics still unanswered, the U.S. National Academies of Sciences, Engineering and Medicine; the United Kingdom’s Royal Society; and the Chinese Academy of Science agreed that “it would be …
The Lancet Dec 15, 2015 Rebecca Cooney, Editor
Gene editing has swiftly become one of the most promising—and controversial—breakthroughs in genetic engineering.
With the entrance of CRISPR (clustered regularly interspaced short palindromic repeats), a technique using the Cas9 enzyme to cut strands of the genome at precisely targeted locations to insert, replace, or remove DNA, the manipulation of the genetic basis of human disease has once again come to the fore.
Much of the excitement …
MSUnites.com Nov 5, 2015
A new stem cell treatment has sent most of the MS patients who tried it into remission, halting the progression of the disease even several years afterwards.
In a recent clinical study at the COloroda Blood Cancer Institute 24 patients with relapsing remitting multiple sclerosis (RRMS) underwent a three month procedure destroying their immune systems and then had their immune systems restarted using stem cell therapy.
The clinical
Please keep the Nebraska Coalition for Ethical Research in mind especially as you shop online this holiday season. Amazon will donate 0.5% of the price of your eligible AmazonSmile purchases to Nebraska Coalition For Ethical Research whenever you shop on AmazonSmile. You may use this link for easier access http://smile.amazon.com/ch/35-2170959…
Three years after a small number of patients with multiple sclerosis (MS) were treated with high-dose immunosuppressive therapy (HDIT) and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS (RRMS) and had improvements in neurological function, according to a study published online by JAMA Neurology.
MS is a degenerative disease and most patients with RRMS who received disease-modifying therapies experience breakthrough disease. Autologous (using a patient’s …
Bone marrow is the spongy tissue inside some of the bones in the body, including the hip and thigh bones. Bone marrow contains immature cells, called stem cells.
Numerous people with blood cancers such as leukemia, lymphoma, sickle cell anemia and other life-threatening diseases, rely on bone marrow or cord blood transplants to save their life.
Healthy bone marrow and blood cells are needed in order to live. When disease affects bone marrow so that …
Sure, 3D printers that can spit out chocolates, create shoes, handcraft cars and help astronauts sound fun and magical, but a lot of scientists are working to make models that aren’t just fun. They’re developing 3D printers that can also save and change lives by printing out functional human organs. Think about it: If we can make organs on demand, patients don’t have to wait as long for transplanted organs. In the United States alone, …
NuVascular Technologies, Inc. has recently obtained exclusive licensing rights to commercialize a breakthrough medical device that will provide a minimally invasive treatment for heart disease, the No. 1 cause of death in the United States accounting for one in every four deaths.
The BioGenerator stem cell device allows the heart to repair itself and could improve heart function in as little as two to four weeks. NuVascular Technologies is teaming up with researchers at both …
